Study says patients in private rooms less likely to get fatal HAI

Hospitals with mostly private rooms had 33 percent fewer central line infections


Patients who stay in private rooms have a reduced risk of central line infections, according to an article on the Becker's Clinical Leadership and Infection Control website.

The study, conducted by researchers at the University of North Texas Health Science Center, looked at the records of more than 1 million patients in 335 Texas hospitals.

The study found that hospitals with mostly private rooms had 33 percent fewer central line infections than hospitals with mostly double occupancy rooms.

The mortality risk due to central line infections was more than twice as high in hospitals with mostly double occupancy rooms.

Read the article.

 

 



August 31, 2018


Topic Area: Infection Control


Recent Posts

The Future of Backup Power Systems in Healthcare Facilities

Manufacturers discuss what trends are shaping the future of backup power systems in healthcare.


Infection Control is Key to Ongoing Measles Outbreak

Infection control is essential to protecting both patients and staff from contracting measles.


Kaiser Permanente to Open New Parker Medical Offices

It also announced it's in the early stages of planning a rebuild and expansion of its Westminster Medical Offices.


Skanska Completes Renovation for New Sutter Health Care Center

The new facility will provide internal medicine, family medicine, pediatrics, as well as lab and imaging services.


Probiotic Cleaners: The Start of a Cleaning Revolution?

Advantages of probiotic cleaning include fewer resistant genes and cost savings through decreased antibiotic use.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.